Literature DB >> 7626349

Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure.

K J Osterziel1, D Hänlein, R Willenbrock, C Eichhorn, F Luft, R Dietz.   

Abstract

OBJECTIVE: To assess the influence of both sympathetic (plasma noradrenaline concentrations) and parasympathetic (baroreflex activation) tone on survival in patients with congestive heart failure.
DESIGN: Invasive study with determination of parasympathetic activity and follow up for at least 4.5 years.
SUBJECTS: 35 patients with sinus rhythm and mild to moderate heart failure (New York Heart Association grades II-III) (mean age 53 (SD 3)).
RESULTS: 20 patients whose hearts survived were compared with 15 patients whose hearts did not (12 died and three received transplants). The two groups differed significantly in terms of mean arterial blood pressure (98 (3) v 90 (3) mm Hg), heart rate (82 (2) v 93 (4) beats/min), and mean pulmonary artery pressure (24 (3) v 35 (2) mm Hg) (all P < 0.05), while cardiac index, stroke volume index, and right atrial pressures were not different. The survivors had significantly lower plasma renin activities (3.6 (0.8) v 9.0 (3.6) angiotensin I/ml/h; P < 0.05) and tended to have lower noradrenaline values than non-survivors (170 (23) v 286 (74) pg/ml) at baseline. Baroreflex sensitivity was significantly lower in non- survivors than in survivors (1.3 (0.2) v 2.3 (0.3) ms/mm/Hg); P < 0.02). As the time of cardiac transplantation is dependent on complex logistical factors the three patients who received a transplant were excluded from the analysis of survival time. The risk of death in relation to baroreflex sensitivity at the median sensitivity of 1.48 ms/mm Hg was calculated. Survival was significantly different (P < 0.04) between the resulting two groups; three of the 16 subjects with high baroreflex sensitivity died compared with nine of the 16 with a baroreflex sensitivity < 1.48 ms/mm Hg. When systemic blood pressure, pulmonary artery pressure, stroke volume index, plasma noradrenaline concentrations, and baroreflex sensitivity were entered into a Cox proportional hazards regression, only systolic blood pressure and plasma noradrenaline values predicted survival (P < 0.001).
CONCLUSIONS: Low vagal tone is correlated with a poor prognosis in patients with heart failure. Sympathetic tone measured as plasma noradrenaline concentration also contributed to survival. An additional contribution of vagal tone to survival could not be shown when sympathetic tone was considered simultaneously. This may be due to the inverse relation of sympathetic and parasympathetic tone and to the insensitivity of the multiple regression method to identify additional risk factors in small numbers of patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626349      PMCID: PMC483912          DOI: 10.1136/hrt.73.6.517

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  27 in total

1.  ACE inhibition improves vagal reactivity in patients with heart failure.

Authors:  K J Osterziel; R Dietz; W Schmid; K Mikulaschek; J Manthey; W Kübler
Journal:  Am Heart J       Date:  1990-11       Impact factor: 4.749

2.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

3.  Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study.

Authors:  M T La Rovere; G Specchia; A Mortara; P J Schwartz
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

4.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Authors:  K Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

Review 5.  Physiology and pharmacology of cardiovascular catecholamine receptors: implications for treatment of chronic heart failure.

Authors:  O E Brodde
Journal:  Am Heart J       Date:  1990-12       Impact factor: 4.749

6.  Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.

Authors:  W H Lee; M Packer
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

7.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

8.  Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction.

Authors:  P J Schwartz; E Vanoli; M Stramba-Badiale; G M De Ferrari; G E Billman; R D Foreman
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

9.  Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.

Authors:  H J Bonnier; R F Visser; H C Klomps; H J Hoffmann
Journal:  Am J Cardiol       Date:  1988-07-01       Impact factor: 2.778

10.  Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.

Authors:  M J Likoff; S L Chandler; H R Kay
Journal:  Am J Cardiol       Date:  1987-03-01       Impact factor: 2.778

View more
  29 in total

1.  Measures of cardiovascular autonomic nervous function: agreement, reproducibility, and reference values in middle age and elderly subjects.

Authors:  J Gerritsen; B J TenVoorde; J M Dekker; R Kingma; P J Kostense; L M Bouter; R M Heethaar
Journal:  Diabetologia       Date:  2003-03-18       Impact factor: 10.122

2.  Prognostic importance of right ventricular dysfunction.

Authors:  R A Bleasdale; M P Frenneaux
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 3.  Predicting cardiovascular risk--the madness is in the methods.

Authors:  Mark W Chapleau
Journal:  Clin Auton Res       Date:  2005-02       Impact factor: 4.435

4.  Dysfunctional baroreflex regulation of sympathetic nerve activity in remitted patients with panic disorder. A new methodological approach.

Authors:  Toshiki Shioiri; Maki Kojima-Maruyama; Toshihiro Hosoki; Hideaki Kitamura; Akira Tanaka; Makoto Yoshizawa; Takehiko Bando; Toshiyuki Someya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-01-14       Impact factor: 5.270

5.  Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.

Authors:  K M Yee; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

6.  Altered ENaC is Associated With Aortic Baroreceptor Dysfunction in Chronic Heart Failure.

Authors:  Yu-Long Li; Dongze Zhang; Huiyin Tu; Robert L Muelleman
Journal:  Am J Hypertens       Date:  2015-08-20       Impact factor: 2.689

7.  Heart rate variability at rest and during mental stress in patients with coronary artery disease: differences in patients with high and low depression scores.

Authors:  D Sheffield; R Krittayaphong; W E Cascio; K C Light; R N Golden; J B Finkel; G Glekas; G G Koch; D S Sheps
Journal:  Int J Behav Med       Date:  1998

Review 8.  [The renin-angiotensin system in cardiovascular diseases].

Authors:  C Unterberg; H Kreuzer; A B Buchwald
Journal:  Med Klin (Munich)       Date:  1998-07-15

9.  Post-exercise heart rate recovery independently predicts mortality risk in patients with chronic heart failure.

Authors:  Yi-Da Tang; Thomas A Dewland; Detlef Wencker; Stuart D Katz
Journal:  J Card Fail       Date:  2009-08-05       Impact factor: 5.712

Review 10.  Carotid body modulation in systolic heart failure from the clinical perspective.

Authors:  Piotr Niewinski
Journal:  J Physiol       Date:  2016-04-13       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.